Assessment of oxidative and endoplasmic reticulum stress markers in women with uterine myomas


Yildirim E. B., MISIR S., Yaman S. O., AKKUŞ A., YILDIZ Ç., ÖZSOY C.

EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, no.5, pp.99-106, 2024 (SCI-Expanded) identifier

  • Publication Type: Article / Article
  • Publication Date: 2024
  • Doi Number: 10.22514/ejgo.2024.097
  • Journal Name: EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Academic Search Premier, BIOSIS, EMBASE
  • Page Numbers: pp.99-106
  • Karadeniz Technical University Affiliated: Yes

Abstract

The most frequent benign gynecological tumor in women who are fertile, uterine myoma significantly lowers quality of life. Endoplasmic reticulum stress (ERS) and oxidative stress (OS) play a role in the development of numerous disease states, including gynecological disorders. In order to determine the ERS and OS levels activated in women with uterine myoma, we sought to measure Total Oxidant Status (TOS) level, Glucose regulatory protein 78 (GRP78), C/EBP homologous protein (CHOP) expression, and protein levels. A total of 40 women with uterine myomas and 40 healthy women were included in the study. Serum levels of TOS, GRP78, CHOP, and protein levels were determined using an enzyme-linked immunosorbent assay (ELISA) kit. Reverse transcription polymerase chain reaction (RT-PCR) performed the mRNA levels of endoplasmic reticulum stress-associated molecules GRP78 and CHOP. The TOS levels, GRP78 and CHOP protein levels were significantly higher in women with myomas than in the controls, with values of p = 0.009, p = 0.001, and p = 0.0001, respectively. GRP78 and CHOP expression increased in women with myomas and were significantly higher than the control group used (p p < 0.05). ROC curve analysis showed that GRP78 and CHOP are promising biomarkers for uterine myomas (area under the curve (AUC): 0.953, AUC: 0.969, p < 0.001, respectively). Oxidative and ERS may play a vital role in the pathophysiology of the disease due to the increased levels of oxidative and ERS markers in women with uterine myomas.